Thomas Wessel

Filings by Thomas Wessel span 2 companies, the busiest being Acorda Therapeutics Inc and Salarius Pharmaceuticals, Inc. The record holds 4 filings, for trades running from 2 March 2009 to 14 March 2016.

The open-market record is one-sided, with 2 purchases worth €142k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants. In 2016 alone, the filings show 2 purchases and no sales.

The latest filing, published on 15 March 2016, reports an open-market purchase of €77k in Salarius Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.